RONN Motor Group

RONN Motor Group completed its acquisition of Lee Pharmaceuticals in a reverse merger transaction on March 30, 2023. RONN Motor Group shareholders received shares of Lee Pharmaceuticals stock on a 1:1 exchange basis, and RONN Motor Group will be the surviving entity.

RONN Motor Group executed a three-way joint venture agreement in China with $100 million registered capital to manufacture, sell and develop hydrogen fuel-cell vehicles, with RONN retaining 51% controlling interest.